ClinConnect ClinConnect Logo
Search / Trial NCT07112404

Pain Intervention With Needling: Pilot Of Integrated Neuromodulation Techniques

Launched by THE UNIVERSITY OF TEXAS MEDICAL BRANCH, GALVESTON · Aug 6, 2025

Trial Information

Current as of August 19, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how dry needling—a treatment where very thin needles are gently inserted into muscles—might help reduce pain and improve quality of life for people with chronic lower back pain. The researchers want to see how three different dry needling sessions affect pain and muscle function in the lower back area. Dry needling is thought to help by increasing blood flow, improving muscle activity, and supporting the nervous system.

Adults between 18 and 65 years old who have had lower back pain for at least three months and experience pain most days are eligible to join, as long as they are not currently receiving other treatments like chiropractic care or injections for their back pain. Participants will go through dry needling sessions and be closely monitored to see how their pain and daily life improve. People with certain health issues, such as nerve problems, infections, or allergies to metals, will not be able to participate. This study is not yet recruiting, but it aims to find out if dry needling could be a helpful option for managing long-term lower back pain.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Both males and females between the ages of 18 and 65 will be included in this study.
  • Phase 1 Inclusion criteria
  • - Healthy adults who report no pain for more than 1 day in the past 3 months in their lumbar region. Lumbar region will include posterior lumber musculature, lumbar spine, sacroiliac pain, or superior gluteal area pain.
  • Phase 2 Inclusion criteria
  • Adults experiencing chronic low back pain. Chronic low back pain will be identified as having pain the lumbar region for at least 3 months. The pain may be constant or episodic in nature.
  • Participants will be included if they experience pain at least 75% of the days in the past 3 months. All pain levels will be included. Lumbar region will include posterior lumber musculature, lumbar spine, sacroiliac pain, or superior gluteal area pain.
  • Exclusion Criteria:
  • Individuals who are currently seeking any form of medical treatment for lumbar conditions beyond routine physician follow-up appointments in order to avoid confounding variables, regardless of pain-free status. These may include, but are not limited to, seeking treatment from a chiropractor, acupuncturist, or massage therapist or medical procedures such as injections into the lumbar region for pain.
  • Additionally, those with previous lumbar surgeries or those with previous major injuries to the lumbar spine that may have resulted in structural abnormalities that may compromise needle placement will be excluded. If surgical procedures did not alter structural alignment, then it will be allowed. For example, an approved procedure may include discectomy or nerve ablation, while a not approved procedure would include a lumbar fusion or scoliosis rod placement.
  • Additionally, if a person is experiencing radicular symptoms from a back injury, despite not feeling the symptoms in the lumbar region, will not be considered. Radicular symptoms will be defined as those present past the knee and/or electrical in nature. Individuals with neurological conditions or those who need the services of another due to cognitive deficits will not be considered for this study.
  • Furthermore, as this study relies on an intact sensory system, participants with conditions that may affect sensory processing (e.g., peripheral neuropathy, skin conditions, or circulatory disorders) will be excluded through careful screening.
  • Additional exclusion criteria
  • Will include the following conditions identified as contraindications for dry needling: those with impaired sensitivity, taking anticoagulants, a compromised immune system, a local or systemic infection, an active tumor, history of lymph node removal, history of autoimmune disease, allergy to metals such as nickel or chromium, history of cosmetic procedures in the area, pregnant individuals, or osteoporosis.
  • Non-English-speaking subjects will be excluded from the study due to the need to understand any communication while dry-needling procedures are taking place.

About The University Of Texas Medical Branch, Galveston

The University of Texas Medical Branch (UTMB) in Galveston is a leading academic institution dedicated to advancing health through innovative research, education, and clinical care. As a prominent sponsor of clinical trials, UTMB leverages its extensive resources, multidisciplinary expertise, and commitment to excellence to facilitate groundbreaking studies that address critical health challenges. With a focus on translating scientific discoveries into effective therapies, UTMB fosters collaboration among researchers, clinicians, and participants to enhance patient outcomes and contribute to the overall advancement of medical knowledge.

Locations

Galveston, Texas, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported